BMJ  2008;336:1327 (14 June), doi:10.1136/bmj.39609.364688.DB

News

Review launched after Harvard psychiatrist failed to disclose industry funding

¹ New York

The first 150 words of the full text of this article appear below.

Findings that a leading Harvard professor of psychiatry failed to report substantial payments that he received from drug companies has caused Harvard Medical School, one of its affiliated hospitals, and the US National Institutes of Health (NIH) to come under fire.

An investigation by the US senator Charles Grassley showed that the psychiatrist, Joseph Biederman, and two of his colleagues, Thomas Spencer and Timothy Wilens, had altogether received more than $4.2m (£2.1m; 2.7m) from drug companies since 2000.

The financial disclosure forms filed by the three doctors, according to Mr Grassley, "were a mess" and made it seem that they had received only "a couple of hundred thousand dollars" in the past seven years (http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname=2008_record&page=S5029&position=all).

Mr Grassley said that the failure of the researchers to report their full income could place Harvard and Massachusetts General Hospital "in jeopardy of violating NIH regulations on conflicts of interest." Such violations . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

US psychiatrist is fired from radio programme for not disclosing drug company ties

Janice Hopkins Tanne
BMJ 2008 337: a2934. [Extract] [Full Text]

US senators inquire into ties between stent makers and doctors

Janice Hopkins Tanne
BMJ 2008 337: a2363. [Extract] [Full Text]

Senator asks psychiatrists’ association about drug company funding

Janice Hopkins Tanne
BMJ 2008 337: a929. [Extract] [Full Text]

Online poll

Find out more>>